LSL Pharma Group Inc. (TSXV:LSL)
0.3900
-0.0150 (-3.70%)
At close: Nov 27, 2025
-8.24% (1Y)
| Market Cap | 47.28M |
| Revenue (ttm) | 26.80M |
| Net Income (ttm) | 2.78M |
| Shares Out | 121.22M |
| EPS (ttm) | 0.02 |
| PE Ratio | 17.19 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 245,500 |
| Average Volume | 74,890 |
| Open | 0.3750 |
| Previous Close | 0.4050 |
| Day's Range | 0.3750 - 0.4100 |
| 52-Week Range | 0.2900 - 0.5300 |
| Beta | -0.29 |
| RSI | 59.35 |
| Earnings Date | Nov 25, 2025 |